Stratifying patients according to the combined expression of CCNE1 and CDC25A revealed the expected pattern across most types of cancer: TTLL11 is downregulated in tumors with high expression of at least one of the two potential TTLL11 upstream regulators (Fig. 6e). This evidence concerns the gene CDC25A and cancer.